Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350 [PMID: 32843936 DOI: 10.4330/wjc.v12.i7.342]
Corresponding Author of This Article
Yousef H Darrat, MD, Attending Physician, Department of Internal Medicine, Veterans Affairs Medical Center, 1101 Veterans Drive, Lexington, KY 40502, United States. ydarat@hotmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jul 26, 2020; 12(7): 342-350 Published online Jul 26, 2020. doi: 10.4330/wjc.v12.i7.342
Table 1 Characteristics of hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
Characteristic
Non-AF (n = 651192)
AF (n = 45745)
P value
Age (mean ± SD, yr)
54 ± 11
65 ± 11
< 0.001
Female, n (%)
171592 (28.3)
9244 (20.2)
< 0.001
Race, n (%)
< 0.001
Caucasian
343516 (65.8)
30624 (76.2)
African American
57718 (11.1)
3674 (9.1)
Hispanic
91439 (17.5)
4130 (10.3)
Medical comorbidity, n (%)
Hypertension
215381 (35.7)
23136 (50.7)
< 0.001
Diabetes mellitus
126047 (20.8)
12282 (26.8)
< 0.001
Prior sternotomy
8602 (1.4)
2926 (6.4)
< 0.001
Chronic pulmonary disease
106826 (17.6)
14176 (31)
< 0.001
Chronic renal failure
62065 (10.3)
9884 (21.6)
< 0.001
Anemia
186205 (30.8)
13771 (30.1)
0.004
Chronic alcohol use
418372 (69.1)
29194 (63.8)
< 0.001
Hypothyroidism
35221 (5.8)
4662 (10.2)
< 0.001
Peripheral vascular disease
16026 (2.6)
3518 (7.7)
< 0.001
Smoking
159957 (26.4)
8420 (18.4)
< 0.001
Coronary artery disease
31636 (5.2)
6994 (15.3)
< 0.001
Hospital characteristic, n (%)
Teaching hospital
303751 (50.4)
22069 (48.4)
< 0.001
Rural area
57619 (9.6)
4378 (9.6)
0.761
Hospital bed-size
< 0.001
Small
72730 (12.1)
5903 (13)
Medium
156654 (26)
11616 (25.5)
Large
373165 (61.9)
28057 (61.6)
Primary payer, n (%)
< 0.001
Medicare/Medicaid
350547 (57.9)
33371 (73)
Private including HMO
140515 (23.2)
8278 (18.1)
Self-pay
72366 (12)
2287 (5)
Table 2 Characteristics of propensity matched hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
Characteristic
Non-AF (n = 45504)
AF (n = 45504)
P value
Age (mean ± SD, yr)
65 ± 11
65 ± 11
0.827
Female, n (%)
9174 (20.2)
9221 (20.3)
0.703
Race, n (%)
0.561
Caucasian
34548 (75.9)
34633 (76.1)
African American
4314 (9.5)
4179 (9.2)
Hispanic
4644 (10.2)
4692 (10.3)
Medical comorbidity, n (%)
Hypertension
23142 (50.9)
22972 (50.5)
0.251
Diabetes mellitus
12456 (27.4)
12229 (26.9)
0.091
Prior sternotomy
2610 (5.7)
2843 (6.2)
0.07
Chronic pulmonary disease
14165 (31.1)
14051 (30.9)
0.404
Chronic renal failure
9595 (21.1)
9751 (21.4)
0.192
Anemia
13623 (29.9)
13690 (30.1)
0.634
Chronic alcohol use
29054 (63.8)
29060 (63.9)
0.972
Hypothyroidism
4456 (9.8)
4603 (10.1)
0.103
Peripheral vascular disease
3420 (7.5)
3463 (7.6)
0.592
Smoking
8264 (18.2)
8405 (18.5)
0.222
Coronary artery disease
6893 (15.1)
6898 (15.2)
0.969
Hospital characteristic, n (%)
Teaching hospital
22061 (48.5)
22129 (48.6)
0.567
Rural area
41154 (90.4)
41141 (90.4)
0.893
Hospital bed-size
0.253
Small
6062 (13.3)
5871 (12.9)
Medium
11469 (25.2)
11569 (25.4)
Large
27973 (61.5)
28064 (61.7)
Primary payer, n (%)
0.052
Medicare/ Medicaid
33277 (73.1)
33138 (72.8)
Private including HMO
8389 (18.4)
8270 (18.2)
Self-pay
2101 (4.6)
2287 (5)
Table 3 In-hospital outcomes of propensity matched hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
Non-AF (n = 45504)
AF (n = 45504)
P value
Clinical outcome, n (%)
In-hospital death
4697 (10.3)
5755 (12.6)
< 0.001
Gastrointestinal bleeding
2329 (5.1)
1995 (4.4)
< 0.001
Blood transfusion
10841 (23.8)
10219 (22.5)
< 0.001
Transient ischemic attack
124 (0.3)
134 (0.3)
0.575
Clinical stroke
496 (1.1)
722 (1.6)
< 0.001
Acute kidney injury
11433 (25.1)
12810 (28.2)
< 0.001
Discharge status, n (%)
< 0.001
Discharged home
27646 (60.8)
25705 (56.5)
Discharged SNF/NH/IC
12242 (26.9)
13114 (28.8)
Length of stay (mean ± SD, d)
7 ± 8
8 ± 10
< 0.001
Hospital cost (mean ± SD, $)
16272 ± 24166
20720 ± 33210
< 0.001
Table 4 The prevalence of atrial fibrillation according to age and gender for in-patients with liver cirrhosis compared to the general in-patient population
Age (yr)
Gender
AF in liver cirrhosis (%)
AF national estimate (%)
< 45
Male
1.70
1.76
Female
0.90
0.88
46-65
Male
5.90
5.91
Female
3.20
3.16
66-85
Male
20.00
20.03
Female
16.00
15.99
> 86
Male
34.10
34.18
Female
33.50
33.60
Citation: Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350